Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sarcopenia in Gestational Diabetes: The SiGnal-D Study

NCT06876090 is registered in ClinicalTrials.gov with Istituto di Neuroscienze Consiglio Nazionale delle Ricerche as lead sponsor.

NCT NCT06876090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06876090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sarcopenia in Gestational Diabetes: The SiGnal-D Study
Lead sponsor
Istituto di Neuroscienze Consiglio Nazionale delle Ricerche
Phase
Observational
Overall status
Recruiting
Start date
May 28, 2025
Completion date
April 30, 2026
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adverse maternal and neonatal outcomes, cognitive function, gestational diabetes mellitus (gdm), pregnancy complications, sarcopenia